|
WO2021048410A1
|
|
Method for determining global bisulfite conversion efficiency
|
|
WO2021034196A1
|
|
Biomarkers for detecting secondary liver cancer
|
|
WO2021009201A1
|
|
Microfluidic device
|
|
WO2021006733A1
|
|
Rapid in vitro t cell exhaustion
|
|
WO2020214033A1
|
|
Papain-like cysteine peptidase medicaments and uses thereof
|
|
WO2020153837A1
|
|
Single cell selection and isolation
|
|
WO2020117051A1
|
|
An insufflator for exposing structures within an internal body cavity
|
|
WO2020067887A1
|
|
Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
|
|
CA3112303A1
|
|
Adenosomes
|
|
WO2020009566A1
|
|
Methods of treating sarcoidosis
|
|
WO2019235923A1
|
|
Role for low density lipoprotein receptor-related protein 10 in progressive brain diseases
|
|
EP3793582A1
|
|
Treatments and biomarkers for the prognosis of zika virus infection
|
|
NL2022777B1
|
|
Artificial sphincter
|
|
GB201901432D0
|
|
Optical coherence elastography imaging
|
|
EP3669937A1
|
|
Flexible 3d-printed water bolus inserts
|
|
NL2022004B1
|
|
A system, a method, a computer program product and an electric stimulation signal
|
|
EP3617731A1
|
|
Magnetic resonance imaging based on transient response signals
|
|
WO2019132654A1
|
|
Methods of treating sarcoidosis
|
|
WO2018226098A2
|
|
Methods for typing neurological disorders and cancer, and devices for use therein
|
|
NL2020410B1
|
|
Stent delivery system
|
